Dosage dependent genes such as MECP2, where mutations cause Rett syndrome (Amir et al., 1999), and the dominant-negative expression of the FBN1 gene in Marfan syndrome (Robinson and Godfrey, 2000) are prime examples where gene transfer therapies are ambitious. This evidence concerns the gene MECP2 and Rett syndrome.